Paradigm Asset Management’s AtriCure ATRC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q3
Sell
-19,300
Closed -$468K 421
2017
Q2
$468K Sell
19,300
-19,900
-51% -$423K 0.09% 237
2017
Q1
$751K Buy
39,200
+3,600
+10% +$63.1K 0.14% 165
2016
Q4
$697K Sell
35,600
-1,100
-3% -$19.9K 0.13% 147
2016
Q3
$581K Sell
36,700
-1,950
-5% -$30K 0.1% 240
2016
Q2
$546K Buy
38,650
+3,000
+8% +$45.7K 0.1% 209
2016
Q1
$600K Sell
35,650
-5,800
-14% -$102K 0.11% 195
2015
Q4
$930K Sell
41,450
-75,050
-64% -$1.55M 0.16% 120
2015
Q3
$2.55M Buy
116,500
+63,000
+118% +$1.57M 0.33% 94
2015
Q2
$1.32M Hold
53,500
0.15% 174
2015
Q1
$1.1M Buy
+53,500
New +$1.04M 0.12% 189

Other funds holding ATRC

Paradigm Asset Management's ATRC Position: Q3 2017 in Review

Paradigm Asset Management sold out of AtriCure (ATRC) in Q3 2017, closing a stake of 19,300 shares — an estimated $468K sold.

Paradigm Asset Management first reported a position in ATRC in Q1 2015 and held it in 10 quarters. The position peaked at $2.55M in Q3 2015. 114 funds tracked by Wall St. Rank hold ATRC as of Q3 2017.

  • Paradigm Asset Management reported no remaining AtriCure position as of Q3 2017 after selling out during the quarter.
  • Paradigm Asset Management sold 19,300 AtriCure shares in Q3 2017, an estimated $468K.
  • Paradigm Asset Management first reported a position in AtriCure in Q1 2015 and held it in 10 quarters.
  • Paradigm Asset Management's AtriCure position peaked at $2.55M in Q3 2015.
  • 114 funds tracked by Wall St. Rank held AtriCure as of Q3 2017.

Based on Paradigm Asset Management's 13F filing for Q3 2017, filed 14 Nov 2017.